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In recent years, one of ASNC's primary initiatives has been to limit patient radiation exposure associated with myocardial perfusion SPECT. A goal was set to reduce exposure to less than 9 mSv in 50% of patients by 2014. 1 Recommendations to accomplish this goal include elimination of Tl-201 and dual isotope protocols; implementation of new low count density software; incorporation of new hardware, including focused collimation and solid state detectors; and utilization of stress-first/stress-only imaging protocols in appropriate patients, facilitated by soft tissue attenuation correction when available. 2, 3 Unfortunately, however, adoption of reduced dose protocols has been slow to catch on in the United States. Barriers to radiation dose reduction have included the cost of hardware and even the relatively minor cost of new software, a lack of regulatory enforcement, and no reimbursement incentive. Jerome et al recently reported that for laboratories participating in certification by the Intersocietal Accreditation Commission 2012-2013 only 1.5% had adopted protocols with associated radiation exposure B9 mSv. 4 It was also recently reported that laboratories in the United States have implement fewer measures to decrease patient radiation dose than non-US facilities. 5 In a recent publication in the Journal of Nuclear Cardiology, ''Evaluation of general-purpose collimators against high-resolution collimators with resolution recovery with a view to reducing radiation dose in myocardial perfusion SPECT: A preliminary phantom study,'' Ian Armstrong et al reported a method by which myocardial perfusion SPECT could be performed with general-purpose collimators instead of high-resolution collimators (currently recommended by ASNC guidelines and in routine use in most laboratories) coupled with commercially available low count density SPECT software. 6 They postulated that although higher sensitivity general-purpose collimators have poorer spatial resolution, resolution recovery algorithms incorporated into new low count density software would compensate for the collimators' loss of spatial resolution. This new method was validated in cardiac phantom experiments using cameras and associated software manufactured by two separate vendors. Although the authors discovered important technical differences between the two vendors' systems, with both they were able to achieve a 35-40% reduction in either SPECT acquisition time or patient radiation exposure.
IMPROVING ON A GOOD THING
Not only are the authors to be congratulated on their investigation and validation of a method to further decrease patient radiation exposure, they should also be commended on their laboratory's routine, non-research myocardial perfusion SPECT protocol. They use a twoday Tc-99m protocol, which minimizes differences in stress versus rest count density and image quality and facilitates stress-first/stress-only imaging. They perform attenuation correction routinely to minimize attenuation artifacts, to optimize test diagnostic specificity, and to further facilitate a stress-first/stress-only protocol. They also routinely perform SPECT image processing using commercially available low-dose software incorporating iterative reconstruction, resolution recovery, and noise reduction, enabling either reduced SPECT acquisition times and/or reduced injected activity. Consequently, their routine two-day protocol uses 7.6 mCi (280 MBq) stress and rest doses, which deliver a total dose of only approximately 6.1 mSv to the patient plus 0.6 mSv for the low-dose attenuation correction CT, well below ASNC's recommendation of 9.0 mSv. As noted above, few nuclear cardiology laboratories in the United States abide by ASNC recommendations to reduce radiation dose. Likewise, only a small minority of laboratories incorporate attenuation correction. Therefore, I feel that this publication serves not only to highlight how old technology can be incorporated to satisfy current goals, but also how a quality practice can be established by protocol modification and incorporation of new hardware and software technology. So myocardial perfusion SPECT can indeed just keep getting better and better!
THE DEVIL'S IN THE DETAILS
In addition to the ability to significantly decrease patient radiation exposure using a combination of general-purpose collimators and reduced count density software, another very significant finding in the report by Armstrong et al are the technical differences required to implement this methodology using the two systems they evaluated, the General Electric Healthcare Infinia TM camera with a LEGP collimator and Evolution TM software versus the Siemens Medical Solutions Symbia T6 TM with a LEAP collimator and Flash 3D TM software. The authors performed a very extensive evaluation of the influence of various technical variables on phantom defect contrast, including matrix/pixel size, camera zoom, and the number of iterations used for iterative reconstruction. Optimal image reconstruction parameters differed between the two vendors. For example, for general-purpose collimator SPECT acquired with a 40% reduction in acquisition time, the GE Infinia camera with a smaller, 4.4 mm pixel size produced superior or comparable images compared to full-time high-resolution collimator imaging. In contrast, for the Siemens Symbia T6 camera, optimal image contrast was achieved using a larger, 6.8 mm pixel size.
COMMERCIAL, EDUCATIONAL, AND POLITICAL RAMIFICATIONS
I recall that in the early days of myocardial perfusion SPECT, the various vendors recommended different Butterworth filters, each best suited to their particular cameras. Nevertheless, some users implemented filters suited to different cameras, which often resulted in suboptimal image quality. Such differences among vendor methods are inevitable. It is therefore imperative that when physicians and technologists implement general-purpose collimation coupled with reduced count density software to reduce patient radiation exposure, they must be familiar with their particular vendor's specifications and recommendations. In turn vendors must systematically identify the necessary variables for their particular cameras and establish clear cut user instructions. One task that the ASNC Technology Committee should consider undertaking is to spearhead a coordinated effort among camera vendors first to identify these technical parameters of their individual systems and then to instruct their users how to implement the technique. Once this is accomplished, ASNC could also assume a role in educating its members regarding the advantages of the technique and appropriate means of implementation. Perhaps the Intesocietal Accreditation Commission should also adopt standards for application of this technique in individual laboratories.
Since advancements in scintillation camera detector technology have provided higher count rate capabilities, in general, Nuclear Medicine high-resolution collimators are adequate for most all applications including blood flow studies (renal, brain, etc.). Therefore, camera vendors are phasing out general-purpose collimators. However, considering the distinct advantage of generalpurpose collimators coupled with low count density cardiac SPECT software demonstrated by Armstrong et al to further decrease patient radiation exposure, vendors may instead want to consider making generalpurpose collimators more widely available, particularly for dedicated cardiac SPECT cameras.
The results of the article by Armstrong et al also reinforce the potential advantage of collaboration between Nuclear Medicine and Nuclear Cardiology laboratories. One obvious example of such collaboration is for cardiac PET. PET/CT cameras are widely available in Nuclear Medicine laboratories but seldom sited in Nuclear Cardiology laboratories. To facilitate the expanded use of PET/CT in Nuclear Cardiology, ASNC's PET Task Force has encouraged sharing of such resources between Nuclear Medicine and Nuclear Cardiology. Similarly, whereas the vast majority of Nuclear Cardiology laboratories perform myocardial perfusion SPECT using high-resolution collimators, general-purpose collimators are presently widely available in most general Nuclear Medicine laboratories. The sharing of cameras equipped with general-purpose collimators could minimize capital expense and optimize resource utilization.
Over a decade ago in a publication in the European Journal of Nuclear Medicine, Lau et al suggested that when resolution reconstruction was incorporated into SPECT image reconstruction, general-purpose collimators were superior to high-resolution collimators. 7 The study was based on mathematically data and a single phantom reconstruction. It is regrettable that it has taken so long to achieve further validation and publication in a journal more readily accessible to physicians, technologists, and basic scientists intimately involved in Nuclear Cardiology. Therefore, the Nuclear Cardiology community should be more attentive to technical developments reported in journals that are not Nuclear Cardiology specific. Perhaps this would be another good task for ASNC's new Technology Committee. Moreover, the editor and associate editors of the Journal of Nuclear Cardiology could perhaps maintain communication with that committee regarding potential areas of further development reported in articles cited in the Journal's monthly review of the literature.
Armstrong et al thoroughly investigated the methodology they reported with experiments in cardiac phantoms and appropriately recommend that prospective patient studies should be undertaken. This is certainly a logical, systematic approach. Too often in nuclear cardiology, we see methods published that have been evaluated only in patients. There are often so many associated patientrelated variables that results are inconclusive and a path to clinical implementation is unclear. The Journal of Nuclear Cardiology and other peer-reviewed journals should therefore insist that new methodologies first be thoroughly evaluated in phantoms before manuscripts reporting patient studies are considered.
PRELIMINARY PATIENT STUDIES
In our laboratory, we have performed myocardial perfusion SPECT on a General Electric Ventri TM dedicated dual-head cardiac camera equipped with generalpurpose parallel hole collimators. Reconstructed SPECT images have been compared to companion scans in the same patients acquired on the same camera equipped with high-resolution collimators. Acquisition times are decreased by 30% using the general-purpose collimators. Data from both acquisitions are processed with low count density software incorporating iterative reconstruction, resolution recovery, and noise reduction tailored for the specifications of the particular camera and collimator. Examples are provided in Figures 1 and  2 . In general, we have found SPECT images to be comparable using the two methods.
CONCLUSIONS
Thanks to the excellent research effort by Armstrong et al, the Nuclear Cardiology community now has yet another tool to further decrease patient radiation exposure and/or SPECT acquisition times. However, patient-based research is necessary prior to widespread clinical implementation. Thereafter, we must be cautious when adopting this methodology in order to assure that camera and software specifications are optimized and satisfied. This responsibility lies not only with vendors and individual users but also with educational and regulatory agencies including the American Society of Nuclear Cardiology, the Journal of Nuclear Cardiology, and the Intersocietal Accreditation Commission. Fig. 2 . A 70-year-old male evaluated for coronary artery disease risk factors and arrhythmia underwent single day, 5.3/ 20.0 mCi rest/exercise stress Tc-99m sestamibi SPECT using a General Electric Ventri TM dual-head camera. All tomograms were reconstructed using UltraSPECT Xpress-3 Wide Beam Reconstruction TM software. (A) Post-stress images acquired for 12 minutes 17 seconds with standard low-energy highresolution collimation are of excellent quality and normal. (B) Resting images acquired for 14 minutes 3 seconds with the LEHR collimator (top row) demonstrate apical thinning and physiologic defects associated with the anterior and inferior right ventricular insertion sites. All of these common features may be exaggerated in very low-dose Wide Beam Reconstruction studies. 8 In resting images re-acquired for 9 minutes 33 seconds with a LEGP collimator (bottom row), myocardial definition remains very good, although slightly less sharp than with the high-resolution collimator. However, the potentially confusing defects present with high-resolution collimator imaging are considerably less prominent. 
